Sonar, Nameeta, BioGenomics Ltd, Maharastra, India., India
-
Vol 19, No 5 (2024) - Original Article
Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid® (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study
Abstract PDF
